Lenzo Salvatore MD New York City, NY - 10075

Lenzo Salvatore MD is categorized under Orthopedic Doctors and Physicians in New York City, NY and active since 1987.

Lenzo Salvatore MD was established in 1987, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Salvatore Lenzo at the company’s single location by writing to 955 5th Avenue, New York City, New York NY 10075 or by phoning (212) 734-9949. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lenzo Salvatore MD
Contact Person: Salvatore Lenzo
Address: 955 5th Avenue, New York City, New York 10075
Phone Number: (212) 734-9949
Website Address: slenzomd.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1987
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Orthopedic Doctors and Physicians
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Lenzo Salvatore MD was started in 1987 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Salvatore Lenzo for inquiries that concern Lenzo Salvatore MD by calling the company number (212) 734-9949, as your correspondence is most welcome. Additionally, the physical location of the single location of Lenzo Salvatore MD can be found at the coordinates 40.774875,-73.962765 as well as the street address 955 5th Avenue in New York City, New York 10075.

For its online presence, you may visit Lenzo Salvatore MD’s website at slenzomd.com and engage with its social media outlets through on Twitter and on Facebook.